←Back to Expert Scholars
Translational Medicine / 转化医学Biliary Tract Cancer Combination Therapy
Milind Javle
MD
🏢MD Anderson Cancer Center🌐USA
Professor of Gastrointestinal Medical Oncology
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Dr. Milind Javle is a leading cholangiocarcinoma investigator at MD Anderson Cancer Center. He has led pivotal trials of FGFR inhibitors including pemigatinib and infigratinib for fibroblast growth factor receptor altered cholangiocarcinoma. His work defines precision medicine approaches in biliary tract cancer.
Share:
🧪Research Fields 研究领域
cholangiocarcinoma
FGFR inhibitors
targeted therapy
clinical trials
biliary tract cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Milind Javle 的研究动态
Follow Milind Javle's research updates
留下邮箱，当我们发布与 Milind Javle（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment